Stadhouders, Lian E.M.Smith, Jonathon A.B.Gabriel, Brendan M.Verbrugge, Sander A.J.Hammersen, Tim D.Kolijn, DetmarVogel, Ilse S.P.Mohamed, Abdalla D.de Wit, Gerard M.J.Offringa, CarlaHoogaars, Willem M.H.Gehlert, SebastianWackerhage, HenningJaspers, Richard T.2023-12-142023-12-142023-12-15Stadhouders, L E M, Smith, J A B, Gabriel, B M, Verbrugge, S A J, Hammersen, T D, Kolijn, D, Vogel, I S P, Mohamed, A D, de Wit, G M J, Offringa, C, Hoogaars, W M H, Gehlert, S, Wackerhage, H & Jaspers, R T 2023, 'Myotube growth is associated with cancer-like metabolic reprogramming and is limited by phosphoglycerate dehydrogenase', Experimental Cell Research, vol. 433, no. 2, 113820. https://doi.org/10.1016/j.yexcr.2023.1138200014-4827ORCID: /0000-0001-6878-8779/work/148966757https://hdl.handle.net/2164/22420Funding Information: Brendan M. Gabriel was supported by fellowships from the Novo Nordisk Foundation ( NNF19OC0055072 ) & the Wenner-Gren Foundation , an Albert Renold Travel Fellowship from the European Foundation for the Study of Diabetes , and an Eric Reid Fund for Methodology from the Biochemical Society . Abdalla D. Mohamed was funded initially by Sarcoma UK (grant number SUK09.2015 ), then supported by funding from Postdoctoral Fellowship Program ( Helmholtz Zentrum München, Germany ), and currently by Cancer Research UK . Publisher Copyright: © 2023 The Authors11426458engSDG 3 - Good Health and Well-beingGlycolysisHypertrophyInsulin-like growth factor IMetabolismSkeletal muscleWarburg effectCell BiologyMyotube growth is associated with cancer-like metabolic reprogramming and is limited by phosphoglycerate dehydrogenaseJournal article10.1016/j.yexcr.2023.113820http://www.scopus.com/inward/record.url?scp=85175096892&partnerID=8YFLogxK4332